Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Breast Neoplasms 46Neoplasms 45Colorectal Neoplasms 29Prostatic Neoplasms 27Lung Neoplasms 27Pancreatic Neoplasms 18Carcinoma, Non-Small-Cell Lung 12Motor Activity 11Head and Neck Neoplasms 11Urinary Bladder Neoplasms 9Ovarian Neoplasms 9Hematologic Neoplasms 9Stomach Neoplasms 8Neoplasm Metastasis 8Anxiety Disorders 8Uterine Cervical Neoplasms 7Multiple Myeloma 6Hematopoietic and Lymphatic System Neoplasm 6Esophageal Neoplasms 6Anatomic Stage I Breast Cancer AJCC v8 6Advanced Cancer 6Triple Negative Breast Neoplasms 5Smoking Cessation 5Rectal Neoplasms 5Radiodermatitis 5Gastrointestinal Neoplasms 5Colonic Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Sarcoma 4Melanoma 4

Interventions

Salpingo-oophorectomy 2Genetic Testing 2Genetic Counseling 2Diet, Mediterranean 2Videotape Recording 1Telemedicine 1Standard of Care 1Specimen Handling 1Salpingectomy 1Practice Guidelines as Topic 1Ovariectomy 1Methods 1Genotype 1Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Hereditary Breast and Ovarian Cancer Syndrome × Standard of Care × Clear all
NCT06534424 2025-06-27

Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study

Ohio State University Comprehensive Cancer Center

Phase NA Completed
152 enrolled
BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡